CTL019 in pediatric and young adult relapsed/refractory acute lymphoblastic leukemia (ALL) patients
Highlights from EHA 2016 press briefings: POLLUX and EURO-SKI trials and BiTE antibodies
Overview of the T-SPOT assay for diagnosing tuberculosis and cytomegalovirus
What is the rationale for novel combination therapies?
Niels van de Donk
Paediatric treatment regimens for acute lymphoblastic leukaemia in adolescents and young adults